This review systematically synthesizes the classification (melanoma skin cancer [MSC], non-melanoma skin cancers [NMSCs]) and global epidemiology of skin cancer based on 2000–2024 literature. MSC, ranking 17th in global prevalence, has the highest incidence and mortality in Europe; NMSCs, 18–20 times more prevalent than MSC and accounting for more skin cancer deaths, show the highest incidence in North America and mortality in Asia. Australia and New Zealand exhibit the highest overall skin cancer incidence. Superficial spreading melanoma is the most common MSC subtype; basal cell carcinoma (BCC) is the most prevalent NMSC, while squamous cell carcinoma (SCC) is the deadliest NMSC.

Its innovation lies in comprehensive continental and subtype-specific epidemiological profiling. Clinically, it highlights the need to standardize incidence/prevalence reporting, investigate rare subtypes (e.g., uveal melanoma), enhance early detection, and apply telemedicine/AI to optimize diagnosis, particularly in resource-limited settings.

Are sports apps only about competition and breaking personal records? Research conducted by scientists from SWPS University shows that cycling enthusiasts in Eastern Europe are increasingly treating digital tools as a path to well-being and comfort, not necessarily as a virtual racetrack.

This review systematically examines the potential of spices and culinary herbs (e.g., turmeric, garlic, ginger) for breast cancer (BC) prevention and treatment, elucidating their underlying mechanisms: inhibiting BC cell proliferation, migration, and metastasis; inducing apoptosis and cell cycle arrest; and modulating dysregulated signaling pathways (e.g., PI3K/Akt/mTOR, NF-κB, Wnt/β-catenin). Notably, their bioactive constituents (e.g., curcumin from turmeric, allicin from garlic, gingerol from ginger) exhibit anti-BC efficacy with fewer adverse effects than conventional chemotherapeutics.

Importantly, it synthesizes in vitro, in vivo, and clinical evidence—for instance, phase I/II trials demonstrating that curcumin combined with docetaxel or paclitaxel improved outcomes in patients with advanced BC. Clinically, these natural agents represent safe, accessible adjuncts to standard BC therapies, though additional large-scale, well-designed clinical trials are required to validate their translational value.

A University of Texas at Arlington study reveals that even children who meet standard developmental milestones may be falling behind in age-appropriate motor skills. Priscila Tamplain, UT Arlington associate professor of kinesiology and director of the Motor Development Lab, has published multiple articles on the topic and cautions parents not to overlook the issue.